Company Information & Drug Savings for Alexion Pharmaceuticals Medications
Alexion Pharmaceuticals, now part of AstraZeneca, is a global biopharmaceutical company focused on rare diseases. Known for Soliris (eculizumab) and Ultomiris (ravulizumab), complement inhibitor therapies for paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), and generalized myasthenia gravis. Alexion pioneered complement biology research and develops life-transforming treatments for patients with devastating rare disorders.
How to Contact Alexion Pharmaceuticals
Phone
1-475-230-2596Medical Disclaimer
NowPatient has taken all reasonable steps to ensure that all material is factually accurate, complete, and current. However, the knowledge and experience of a qualified healthcare professional should always be sought after instead of using the information on this page. Before taking any drug, you should always speak to your doctor or another qualified healthcare provider.
The information provided here about medications is subject to change and is not meant to include all uses, precautions, warnings, directions, drug interactions, allergic reactions, or negative effects. The absence of warnings or other information for a particular medication does not imply that the medication or medication combination is appropriate for all patients or for all possible purposes.
Experienced a Side Effect?
Report to Yellow Card (UK) or MedWatch (US)
